Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 11;16(3):e55979.
doi: 10.7759/cureus.55979. eCollection 2024 Mar.

Temporary Spinal Cord Stimulation for Herpes Zoster With Myelitis: A Case Series

Affiliations

Temporary Spinal Cord Stimulation for Herpes Zoster With Myelitis: A Case Series

Reon Kobayashi et al. Cureus. .

Abstract

Introduction: Preventing the development of postherpetic neuralgia (PHN), the most prevalent and severe complication of herpes zoster (HZ), is vital. Recently, it has been suggested that using temporary spinal cord stimulation (tSCS) for 10-14 days can improve HZ-associated pain (ZAP) and prevent PHN. However, myelitis complicates HZ. Permanent SCS has been successful in treating neuropathic pain induced by postoperative transverse myelitis of the spine that has not responded to traditional multidisciplinary treatment. However, it is unknown whether tSCS can reduce ZAP complicated with myelitis. Methodology: Between January 2020 and April 2022, all patients with HZ who visited our pain clinic with spinal cord edema and who underwent tSCS were enrolled in this study; their medical records were retrospectively examined. Pain intensity was assessed at baseline (before initiating interventional procedures), just before tSCS, after tSCS removal, and one and three months after tSCS. Results: Twelve patients were enrolled. The mean Numerical Rating Scale (NRS) was 7.9 ± 1.6 at baseline (before interventional procedures), 6.8 ± 2.2 before tSCS (after interventional procedures), and 3.5 ± 2.4 after tSCS. Compared with before tSCS, the mean NRS decreased to 3.3 ± 2.3 after tSCS (P = 0.0004). The mean NRS changes with interventional procedures before and after tSCS were -1.2 ± 2.2 (P = 0.0945) and 3.3 ± 2.3 (P = 0.0004), respectively; the change after tSCS was significantly higher (between-group difference: -2.1 ± 3.7; P = 0.0324). Conclusions: Temporary SCS alleviated pain in cases of shingles with myelitis refractory to interventional therapy. Even in cases with myelitis, tSCS for ZAP remains an effective way to prevent PHN.

Keywords: herpes zoster; myelitis; postherpetic neuralgia; spinal cord stimulation; zoster-associated pain.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Change in NRS from baseline.
*Significantly lower than NRS before tSCS (< 0.05). NRS, Numerical Rating Scale; tSCS, temporary spinal cord stimulation
Figure 2
Figure 2. Change in myelitis of case 2.
Arrows indicate unilateral edema in case 2. (A) Before tSCS: one month after HZ onset; (B) thinning: 19 months after HZ onset; (C) disappeared: 30 months after HZ onset. The high-signal region within the spinal cord is gradually thinning. tSCS, temporary spinal cord stimulation; HZ, herpes zoster
Figure 3
Figure 3. MRI image of edema.
(A) Arrows indicate a bilateral edema in case 1; (B) arrows indicate an edema of the anterior horn of the spinal cord in case 9. MRI, magnetic resonance imaging

Similar articles

References

    1. The global epidemiology of herpes zoster. Yawn BP, Gilden D. Neurology. 2013;81:928–930. - PMC - PubMed
    1. Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Arani RB, Soong SJ, Weiss HL, Wood MJ, Fiddian PA, Gnann JW, Whitley R. Stat Med. 2001;20:2429–2439. - PubMed
    1. Systematic review of incidence and complications of herpes zoster: towards a global perspective. Kawai K, Gebremeskel BG, Acosta CJ. BMJ Open. 2014;4:0. - PMC - PubMed
    1. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T. BMC Med. 2010;8:37. - PMC - PubMed
    1. Neurologic complications of the reactivation of varicella-zoster virus. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. N Engl J Med. 2000;342:635–645. - PubMed

LinkOut - more resources